WST:West Pharmaceutical Services Inc Snapshot | Charting | News | Options
$210.89 NYSE 12:44p ET
July 14 '25 		Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against West Pharmaceutical... ACCESSWIRE
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against West Pharmaceutical Services, Inc. (WST) And Encourages Stockholders to Reach Out
     ACCESSWIRE

    NEW YORK, NY / ACCESS Newswire / July 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST). Investors who purchased West securities prior to February 16, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/WST.

    Full Story →

    Headline News
    WEST ALERT: Bragar Eagel & Squire, P.C. is Investigating West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    9:00p ET July 8 '25 GlobeNewswire
    West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights - WST
    3:19p ET July 8 '25 GlobeNewswire
    West to Host Second-Quarter 2025 Conference Call
    6:00a ET July 8 '25 PR Newswire
    More News →
    Day  4.83%Week  7.17%Month  3.24%More Charting →
    July 18 '25. Markets Closed.
    Last $210.89
    Day change   4.83%$10.70
    Open $222.69
    Gap at open $1.10
    Previous close $221.59
    Trading volume 1,473,787
    10 Day avg vol. 604,485
    Shares out. 71.8Mil
    Market cap. $15.2Bil
    Trading activity Above Avg.
    Previous data from yesterday, July 17 '25.

    Historical Price Performance
    3 month   4.45% 
    6 month   37.30% 
    1 year   33.33% 
    2 year   45.31% 

    Earnings
    Previous 12m $6.37
    Next 12m Estimate $6.28
    P/E ratio 34.8x
    Revenue 2,896Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2025 All rights reserved.